Cadrenal Therapeutics, Inc.
NASDAQ: CVKD
$1.22
as on
Cadrenal Therapeutics, Inc. Stock Performance
as on September 5, 2026 at 2:16 pm IST
Day's Low
Day's High
$1.20$1.29
1.64%
Downside
5.74%
Upside
52 Week's Low
52 Week's High
$1.27$14.64-4.10%
Downside
1100.00%
Upside
Cadrenal Therapeutics, Inc. share price movements today
- Previous Close
- $1.28
- Open
- $1.29
- Volume
- 971.4K
- Market Cap
- $4.6M
- Day's Low - High
- $1.20 - $1.29
- 52 Week Low - High
- $1.27 - $14.64
Cadrenal Therapeutics, Inc. Historical Returns
- 1 Month Return
- -36.95 %
- 3 Month Return
- -70.3 %
- 1 Year Return
- -89.77 %
- 3 Year Return
- -90.42 %
- 5 Year Return
- 0 %
Cadrenal Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Cadrenal Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.6M
EPS (TTM)
-4.9
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.26
Industry PE ratio
-1.63
PEG Ratio
-0.0038702914640194224
EBITDA
-11.6M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-406.38%
Cadrenal Therapeutics, Inc. Stock Valuation
Track how Cadrenal Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Cadrenal Therapeutics, Inc. in the last 4 years
Lowest (-7.14x)
December 31, 2022
Industry (-1.63x)
March 31, 2026
Today (-1.02x)
March 31, 2026
Highest (-1.02x)
March 31, 2026
Today’s Price to Earnings Ratio: -1.02x
Cadrenal Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Cadrenal Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $4.6M | NA | -0.26 | 0.00% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $141.1B | 181.73% | 32.21 | 86.04% | NA | |
| BUY | $60.2B | -64.27% | -18.66 | -12.57% | NA | |
| BUY | $84.8B | 24.12% | 20.14 | 84.86% | 0.44% |
Stock Returns calculator for Cadrenal Therapeutics, Inc. Stock including INR - Dollar returns
The Cadrenal Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Cadrenal Therapeutics, Inc. investment value today
Current value as on today
₹10,474
Returns
Returns from Cadrenal Therapeutics, Inc. Stock
Dollar Impact
₹722 (+0.72%)
Analyst Recommendation on Cadrenal Therapeutics, Inc. Stock
Based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Cadrenal Therapeutics, Inc.. Average target price of $14
Cadrenal Therapeutics, Inc. Share Price Target
Get share price movements and forecasts by analysts on Cadrenal Therapeutics, Inc..
What analysts predicted
91.29%UPSIDE
Target Price
$14
Current Price
$1.22
Analyzed by
2 Analysts
Target
$14.00
Cadrenal Therapeutics, Inc. target price $14, a slight upside of 91.29% compared to current price of $1.22. According to 2 analysts rating.
Indian Investors' Interest in Cadrenal Therapeutics, Inc. Stock
Search interest for Cadrenal Therapeutics, Inc. Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:2% versus previous 30 day period
Cadrenal Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Cadrenal Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Cadrenal Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Cadrenal Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Cadrenal Therapeutics, Inc. News & Key Events
Today's Timeline - 31 August
Mon, 06:28 PM
-Cadrenal Therapeutics receives positive FDA feedback on CAD-1005 Phase 3 study protocol for heparin-induced thrombocytopenia.
Insights on Cadrenal Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 34.5% return, outperforming this stock by 125.4%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 479.0% return, outperforming this stock by 569.8%
NEGATIVE IMPACTPrice Dip
In the last 7 days, CVKD stock has moved down by -20.8%
About Cadrenal Therapeutics, Inc.
| Organisation | Cadrenal Therapeutics, Inc. |
| Headquarters | 822 A1A North, Ponte Vedra, FL, United States, 32082 |
| Industry | Biotechnology |
| CEO | Mr. Quang X. Pham |
| E-voting on shares | Click here to vote |
Key Management of Cadrenal Therapeutics, Inc.
Name | Title |
|---|---|
Mr. Jeffrey Cole | Chief Operating Officer |
Mr. Quang X. Pham | Chairman & CEO |
Mr. John P. Sharp CPA | Interim CFO & Principal Accounting Officer |
FAQs
What is Cadrenal Therapeutics, Inc. share price today?
Cadrenal Therapeutics, Inc. share price today is $1.22 as on at the close of the market. Cadrenal Therapeutics, Inc. share today touched a day high of $1.29 and a low of $1.20.
What is the 52 week high and 52 week low for Cadrenal Therapeutics, Inc. share?
Cadrenal Therapeutics, Inc. share touched a 52 week high of $14.64 on and a 52 week low of $1.27 on . Cadrenal Therapeutics, Inc. stock price today i.e. is closed at $1.22,which is 91.67% down from its 52 week high and -3.94% up from its 52 week low.
What is Cadrenal Therapeutics, Inc.'s market capitalisation today?
Cadrenal Therapeutics, Inc. market capitalisation is $0.00T as on .
How to invest in Cadrenal Therapeutics, Inc. Stock (CVKD) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Cadrenal Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cadrenal Therapeutics, Inc. Shares that will get you 1.2295 shares as per Cadrenal Therapeutics, Inc. share price of $1.22 per share as on September 5, 2026 at 8:46 am IST.
What is the minimum amount required to buy Cadrenal Therapeutics, Inc. Stock (CVKD) from India?
Indian investors can start investing in Cadrenal Therapeutics, Inc. (CVKD) shares with as little as ₹94.49 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.90 in Cadrenal Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Cadrenal Therapeutics, Inc. share’s latest price of $1.22 as on September 5, 2026 at 8:46 am IST, you will get 8.1967 shares of Cadrenal Therapeutics, Inc.. Learn more about
fractional shares .